Lonza Reports Record-Breaking Financial Performance, Resulting in 24.2% CORE EBIT Growth, Driven by Pharma&Biotech
. Strong sales growth of 8.7% to CHF 4.13 billion Excellent CORE EBIT of CHF 651 million, up by 24.2% CORE RONOA impr…
. Strong sales growth of 8.7% to CHF 4.13 billion Excellent CORE EBIT of CHF 651 million, up by 24.2% CORE RONOA impr…
. • On-trend: the rugged beauty of black takes hold in the bathroom • Bathroom furniture specialist burgbad presents opt…
Keeping pace with globalisation, AFG Arbonia-Forster-Holding AG has continuously built up its business activities in the…